Literature DB >> 30102230

Sex as a predictor of response to cancer immunotherapy - Authors' reply.

Fabio Conforti1, Laura Pala2, Vincenzo Bagnardi3, Tommaso De Pas2, Martinetti Marco3, Giuseppe Viale4, Richard Gelber5, Aron Goldhirsch2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30102230     DOI： 10.1016/S1470-2045(18)30535-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  The role of immune checkpoint inhibitors in clinical practice: an analysis of the treatment patterns, survival and toxicity rates by sex.

Authors:  Murielle N Wahli; Stefanie Hayoz; Dennis Hoch; Christoph O Ryser; Michèle Hoffmann; Amina Scherz; Birgit Schwacha-Eipper; Simon Häfliger; Julian Wampfler; Martin D Berger; Urban Novak; Berna C Özdemir
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-23       Impact factor: 4.322

Review 2.  Sexual dimorphism in solid and hematological malignancies.

Authors:  Isabel Ben-Batalla; María Elena Vargas-Delgado; Lara Meier; Sonja Loges
Journal:  Semin Immunopathol       Date:  2018-10-25       Impact factor: 9.623

Review 3.  Sex-biased adaptive immune regulation in cancer development and therapy.

Authors:  Johanna M Schafer; Tong Xiao; Hyunwoo Kwon; Katharine Collier; Yuzhou Chang; Hany Abdel-Hafiz; Chelsea Bolyard; Dongjun Chung; Yuanquan Yang; Debasish Sundi; Qin Ma; Dan Theodorescu; Xue Li; Zihai Li
Journal:  iScience       Date:  2022-07-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.